Ski-interacting protein (SKIP) interacts with androgen receptor in the nucleus and modulates androgen-dependent transcription

BMC Biochemistry

Volumn 14, Issue 1, 2013, Pages

  Abankwa, Daniel ^a,f   Millard, Susan M ^a,b   Martel, Nick ^a,b   Choong, Catherine S ^c   Yang, Miao ^d   Butler, Lisa M ^d   Buchanan, Grant ^d   Tilley, Wayne D ^d   Ueki, Nobuhide ^e   Hayman, Michael J ^e   Leong, Gary M ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MATER CHILDREN S HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e STONY BROOK UNIVERSITY   (United States)

^f ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; CELL PROTEIN; MESSENGER RNA; SKI INTERACTING PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DNA TRANSCRIPTION; EMBRYO; FLUORESCENCE RESONANCE ENERGY TRANSFER; HORMONAL REGULATION; HORMONE RECEPTOR TRANSLOCATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIGAND BINDING; MALE; PROSTATE CANCER; PROTEIN INTERACTION; RNA SPLICING; SPLICEOSOME; TRANSACTIVATION; TWO HYBRID SYSTEM;

ANIMALS; CELL LINE, TUMOR; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; COS CELLS; DIHYDROTESTOSTERONE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENES, REPORTER; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; MALE; NUCLEAR RECEPTOR COACTIVATORS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANDROGEN; TRANSCRIPTIONAL ACTIVATION;

EID: 84875856479     PISSN: None     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-14-10     Document Type: Article

References (65)

1. The human Ski-interacting protein functionally substitutes for the yeast PRP45 gene. Figueroa JD, Hayman MJ, Biochem Biophys Res Commun 2004 319 4 1105 1109 10.1016/j.bbrc.2004.05.096 15194481 (Pubitemid 38759525)
2. Transcriptional coregulator SNW/SKIP: the concealed tie of dissimilar pathways. Folk P, Puta F, Skruzny M, Cell Mol Life Sci 2004 61 6 629 640 10.1007/s00018-003-3215-4 15052407 (Pubitemid 38446408)
3. SKIP is an indispensable factor for Caenorhabditis elegans development. Kostrouchova M, Housa D, Kostrouch Z, Saudek V, Rall JE, Proc Natl Acad Sci USA 2002 99 14 9254 9259 10.1073/pnas.112213799 12084813 (Pubitemid 34764600)
4. Inducible RNA interference uncovers the Drosophila protein Bx42 as an essential nuclear cofactor involved in Notch signal transduction. Negeri D, Eggert H, Gienapp R, Saumweber H, Mech Dev 2002 117 1-2 151 162 12204255 (Pubitemid 36158719)
5. The Ski oncoprotein interacts with Skip, the human homolog of Drosophila Bx42. Dahl R, Wani B, Hayman MJ, Oncogene 1998 16 12 1579 1586 10.1038/sj.onc.1201687 9569025 (Pubitemid 28159905)
6. Identification and characterization of Prp45p and Prp46p, essential pre-mRNA splicing factors. Albers M, Diment A, Muraru M, Russell CS, Beggs JD, RNA 2003 9 1 138 150 10.1261/rna.2119903 12554883 (Pubitemid 36206309)
7. Ski-interacting protein, a bifunctional nuclear receptor coregulator that interacts with N-CoR/SMRT and p300. Leong GM, Subramaniam N, Issa LL, Barry JB, Kino T, Driggers PH, Hayman MJ, Eisman JA, Gardiner EM, Biochem Biophys Res Commun 2004 315 4 1070 1076 10.1016/j.bbrc.2004.02.004 14985122 (Pubitemid 38249412)
8. Ski-interacting protein interacts with Smad proteins to augment transforming growth factor-beta-dependent transcription. Leong GM, Subramaniam N, Figueroa J, Flanagan JL, Hayman MJ, Eisman JA, Kouzmenko AP, J Biol Chem 2001 276 21 18243 18248 10.1074/jbc.M010815200 11278756
9. Xenopus skip modulates Wnt/beta-catenin signaling and functions in neural crest induction. Wang Y, Fu Y, Gao L, Zhu G, Liang J, Gao C, Huang B, Fenger U, Niehrs C, Chen YG, J Biol Chem 2010 285 14 10890 10901 10.1074/jbc.M109.058347 20103590
10. SKIP counteracts p53-mediated apoptosis via selective regulation of p21Cip1 mRNA splicing. Chen Y, Zhang L, Jones KA, Genes Dev 2011 25 7 701 716 10.1101/gad.2002611 21460037
11. Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways. Edwards DP, Wardell SE, Boonyaratanakornkit V, J Steroid Biochem Mol Biol 2002 83 1-5 173 186 12650714 (Pubitemid 37040654)
12. Isolation and characterization of a novel coactivator protein, NCoA-62, involved in vitamin D-mediated transcription. Baudino TA, Kraichely DM, Jefcoat SC Jr, Winchester SK, Partridge NC, MacDonald PN, J Biol Chem 1998 273 26 16434 16441 10.1074/jbc.273.26.16434 9632709 (Pubitemid 28311425)
13. Ternary complexes and cooperative interplay between NCoA-62/Ski- interacting protein and steroid receptor coactivators in vitamin D receptor-mediated transcription. Zhang C, Baudino TA, Dowd DR, Tokumaru H, Wang W, MacDonald PN, J Biol Chem 2001 276 44 40614 40620 10.1074/jbc.M106263200 11514567
14. Nuclear coactivator-62 kDa/Ski-interacting protein is a nuclear matrix-associated coactivator that may couple vitamin D receptor-mediated transcription and RNA splicing. Zhang C, Dowd DR, Staal A, Gu C, Lian JB, van Wijnen AJ, Stein GS, MacDonald PN, J Biol Chem 2003 278 37 35325 35336 10.1074/jbc.M305191200 12840015 (Pubitemid 37102301)
15. Interactions of SKIP/NCoA-62, TFIIB, and retinoid X receptor with vitamin D receptor helix H10 residues. Barry JB, Leong GM, Church WB, Issa LL, Eisman JA, Gardiner EM, J Biol Chem 2003 278 10 8224 8228 10.1074/jbc.C200712200 12529369 (Pubitemid 36800566)
16. Reciprocal roles of SIRT1 and SKIP in the regulation of RAR activity: implication in the retinoic acid-induced neuronal differentiation of P19 cells. Kang MR, Lee SW, Um E, Kang HT, Hwang ES, Kim EJ, Um SJ, Nucleic Acids Res 2010 38 3 822 831 10.1093/nar/gkp1056 19934264
17. A human splicing factor, SKIP, associates with P-TEFb and enhances transcription elongation by HIV-1 Tat. Bres V, Gomes N, Pickle L, Jones KA, Genes Dev 2005 19 10 1211 1226 10.1101/gad.1291705 15905409 (Pubitemid 40696187)
18. SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation. Bres V, Yoshida T, Pickle L, Jones KA, Mol Cell 2009 36 1 75 87 10.1016/j.molcel.2009.08.015 19818711
19. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Wang Q, Li W, Zhang Y, Yuan X, Xu K, Yu J, Chen Z, Beroukhim R, Wang H, Lupien M, Cell 2009 138 2 245 256 10.1016/j.cell.2009.04.056 19632176
20. Molecular cell biology of androgen receptor signalling. Bennett NC, Gardiner RA, Hooper JD, Johnson DW, Gobe GC, Int J Biochem Cell Biol 2010 42 6 813 827 10.1016/j.biocel.2009.11.013 19931639
21. Androgen receptor in prostate cancer. Heinlein CA, Chang C, Endocr Rev 2004 25 2 276 308 10.1210/er.2002-0032 15082523 (Pubitemid 38501396)
22. Molecular biology of the androgen receptor. Gelmann EP, J Clin Oncol 2002 20 13 3001 3015 10.1200/JCO.2002.10.018 12089231 (Pubitemid 34728896)
23. Androgen receptor structural and functional elements: role and regulation in prostate cancer. Dehm SM, Tindall DJ, Mol Endocrinol 2007 21 12 2855 2863 10.1210/me.2007-0223 17636035 (Pubitemid 350223500)
24. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Wang Q, Li W, Liu XS, Carroll JS, Janne OA, Keeton EK, Chinnaiyan AM, Pienta KJ, Brown M, Mol Cell 2007 27 3 380 392 10.1016/j.molcel.2007.05.041 17679089 (Pubitemid 47126935)
25. Androgen receptor (AR) coregulators: an overview. Heinlein CA, Chang C, Endocr Rev 2002 23 2 175 200 10.1210/er.23.2.175 11943742 (Pubitemid 34299023)
26. Chemistry and structural biology of androgen receptor. Gao W, Bohl CE, Dalton JT, Chem Rev 2005 105 9 3352 3370 10.1021/cr020456u 16159155 (Pubitemid 41430813)
27. Intermolecular NH2-/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity. Langley E, Kemppainen JA, Wilson EM, J Biol Chem 1998 273 1 92 101 10.1074/jbc.273.1.92 9417052 (Pubitemid 28042181)
28. The NH(2)-terminal and carboxyl-terminal interaction in the human androgen receptor. He B, Wilson EM, Mol Genet Metab 2002 75 4 293 298 10.1016/S1096-7192(02)00009-4 12051960 (Pubitemid 34971578)
29. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Zhou ZX, Lane MV, Kemppainen JA, French FS, Wilson EM, Mol Endocrinol 1995 9 2 208 218 10.1210/me.9.2.208 7776971
30. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. He B, Kemppainen JA, Wilson EM, J Biol Chem 2000 275 30 22986 22994 10.1074/jbc.M002807200 10816582 (Pubitemid 30646187)
31. Androgen-induced NH2- and COOH-terminal Interaction Inhibits p160 coactivator recruitment by activation function 2. He B, Bowen NT, Minges JT, Wilson EM, J Biol Chem 2001 276 45 42293 42301 10.1074/jbc.M107492200 11551963 (Pubitemid 37371140)
32. Nuclear receptor coregulators: cellular and molecular biology. McKenna NJ, Lanz RB, O'Malley BW, Endocr Rev 1999 20 3 321 344 10.1210/er.20.3.321 10368774 (Pubitemid 30649811)
33. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Tora L, White J, Brou C, Tasset D, Webster N, Scheer E, Chambon P, Cell 1989 59 3 477 487 10.1016/0092-8674(89)90031-7 2805068 (Pubitemid 19284461)
34. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. Danielian PS, White R, Lees JA, Parker MG, EMBO J 1992 11 3 1025 1033 1372244
35. Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells. Dehm SM, Tindall DJ, J Biol Chem 2006 281 38 27882 27893 10.1074/jbc.M605002200 16870607 (Pubitemid 44414500)
36. A unified nomenclature system for the nuclear receptor superfamily. Cell 1999 97 2 161 163 10219237
37. The presence of both the amino- and carboxyl-terminal domains in the AR is essential for the completion of a transcriptionally active form with coactivators and intranuclear compartmentalization common to the steroid hormone receptors: a three-dimensional imaging study. Saitoh M, Takayanagi R, Goto K, Fukamizu A, Tomura A, Yanase T, Nawata H, Mol Endocrinol 2002 16 4 694 706 10.1210/me.16.4.694 11923466 (Pubitemid 34297740)
38. Subnuclear organelles: new insights into form and function. Handwerger KE, Gall JG, Trends Cell Biol 2006 16 1 19 26 10.1016/j.tcb.2005.11.005 16325406 (Pubitemid 43077091)
39. Nuclear speckles: a model for nuclear organelles. Lamond AI, Spector DL, Nat Rev Mol Cell Biol 2003 4 8 605 612 10.1038/nrm1172 12923522 (Pubitemid 36934962)
40. Purification and biochemical characterization of interchromatin granule clusters. Mintz PJ, Patterson SD, Neuwald AF, Spahr CS, Spector DL, EMBO J 1999 18 15 4308 4320 10.1093/emboj/18.15.4308 10428969 (Pubitemid 29364133)
41. A novel androgen receptor amino terminal region reveals two classes of amino/carboxyl interaction-deficient variants with divergent capacity to activate responsive sites in chromatin. Need EF, Scher HI, Peters AA, Moore NL, Cheong A, Ryan CJ, Wittert GA, Marshall VR, Tilley WD, Buchanan G, Endocrinology 2009 150 6 2674 2682 10.1210/en.2008-1181 19282387
42. Transcriptional activation and nuclear targeting signals of the human androgen receptor. Simental JA, Sar M, Lane MV, French FS, Wilson EM, J Biol Chem 1991 266 1 510 518 1985913 (Pubitemid 21906153)
43. A novel genetic system to detect protein-protein interactions. Fields S, Song O, Nature 1989 340 6230 245 246 10.1038/340245a0 2547163 (Pubitemid 19171591)
44. The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Chien CT, Bartel PL, Sternglanz R, Fields S, Proc Natl Acad Sci USA 1991 88 21 9578 9582 10.1073/pnas.88.21.9578 1946372 (Pubitemid 21915674)
45. A FRET map of membrane anchors suggests distinct microdomains of heterotrimeric G proteins. Abankwa D, Vogel H, J Cell Sci 2007 120 Pt 16 2953 2962 17690305 (Pubitemid 47394269)
46. Forster distances between green fluorescent protein pairs. Patterson GH, Piston DW, Barisas BG, Anal Biochem 2000 284 2 438 440 10.1006/abio.2000.4708 10964438
47. Fanciful FRET. Vogel SS, Thaler C, Koushik SV, Sci STKE 2006 2006 331 e2 16622184
48. FRET or no FRET: a quantitative comparison. Berney C, Danuser G, Biophys J 2003 84 6 3992 4010 10.1016/S0006-3495(03)75126-1 12770904 (Pubitemid 36637892)
49. Nuclear pre-mRNA compartmentalization: trafficking of released transcripts to splicing factor reservoirs. Melcak I, Cermanova S, Jirsova K, Koberna K, Malinsky J, Raska I, Mol Biol Cell 2000 11 2 497 510 10679009 (Pubitemid 30112160)
50. Cell biology of transcription and pre-mRNA splicing: nuclear architecture meets nuclear function. Misteli T, J Cell Sci 2000 113 Pt 11 1841 1849 10806095 (Pubitemid 30386488)
51. Nuclear speckles. Spector DL, Lamond AI, Cold Spring Harb Perspect Biol 2011 3 2
52. Activation function-1 domain of androgen receptor contributes to the interaction between subnuclear splicing factor compartment and nuclear receptor compartment. Identification of the p102 U5 small nuclear ribonucleoprotein particle-binding protein as a coactivator for the receptor. Zhao Y, Goto K, Saitoh M, Yanase T, Nomura M, Okabe T, Takayanagi R, Nawata H, J Biol Chem 2002 277 33 30031 30039 10.1074/jbc.M203811200 12039962
53. The ubiquitin-specific protease USP10 modulates androgen receptor function. Faus H, Meyer HA, Huber M, Bahr I, Haendler B, Mol Cell Endocrinol 2005 245 1-2 138 146 16368182
54. Cloning and characterization of an androgen receptor N-terminal- interacting protein with ubiquitin-protein ligase activity. Beitel LK, Elhaji YA, Lumbroso R, Wing SS, Panet-Raymond V, Gottlieb B, Pinsky L, Trifiro MA, J Mol Endocrinol 2002 29 1 41 60 10.1677/jme.0.0290041 12200228 (Pubitemid 34965745)
55. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. Lin HK, Altuwaijri S, Lin WJ, Kan PY, Collins LL, Chang C, J Biol Chem 2002 277 39 36570 36576 10.1074/jbc.M204751200 12119296
56. Nuclear compartmentalization of N-CoR and its interactions with steroid receptors. Wu Y, Kawate H, Ohnaka K, Nawata H, Takayanagi R, Mol Cell Biol 2006 26 17 6633 6655 10.1128/MCB.01534-05 16914745 (Pubitemid 44304271)
57. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth. Hsu CL, Chen YL, Ting HJ, Lin WJ, Yang Z, Zhang Y, Wang L, Wu CT, Chang HC, Yeh S, Mol Endocrinol 2005 19 2 350 361 15514032 (Pubitemid 40223460)
58. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Bevan CL, Hoare S, Claessens F, Heery DM, Parker MG, Mol Cell Biol 1999 19 12 8383 8392 10567563 (Pubitemid 30414032)
59. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW, Invest Urol 1979 17 1 16 23 447482 (Pubitemid 9239413)
60. Infection of Human and Simian Tissue Cultures with Rous Sarcoma Virus. Jensen FC, Girardi AJ, Gilden RV, Koprowski H, Proc Natl Acad Sci USA 1964 52 53 59 10.1073/pnas.52.1.53 14192657
61. Characterization of Brx, a novel Dbl family member that modulates estrogen receptor action. Rubino D, Driggers P, Arbit D, Kemp L, Miller B, Coso O, Pagliai K, Gray K, Gutkind S, Segars J, Oncogene 1998 16 19 2513 2526 10.1038/sj.onc.1201783 9627117 (Pubitemid 28258583)
62. Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variant. Butler LM, Centenera MM, Neufing PJ, Buchanan G, Choong CS, Ricciardelli C, Saint K, Lee M, Ochnik A, Yang M, Mol Endocrinol 2006 20 5 1009 1024 10.1210/me.2004-0401 16423882
63. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Irvine RA, Ma H, Yu MC, Ross RK, Stallcup MR, Coetzee GA, Hum Mol Genet 2000 9 2 267 274 10.1093/hmg/9.2.267 10607837 (Pubitemid 30052750)
64. Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function. Buchanan G, Yang M, Harris JM, Nahm HS, Han G, Moore N, Bentel JM, Matusik RJ, Horsfall DJ, Marshall VR, Mol Endocrinol 2001 15 1 46 56 10.1210/me.15.1.46 11145738 (Pubitemid 32156040)
65. Quantitative fluorescence resonance energy transfer measurements using fluorescence microscopy. Gordon GW, Berry G, Liang XH, Levine B, Herman B, Biophys J 1998 74 5 2702 2713 10.1016/S0006-3495(98)77976-7 9591694 (Pubitemid 28225264)